Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Clinical trial NCT02531113 · COMPLETED

Trial details

NCT number: NCT02531113
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2015-10-09
Primary completion: 2019-09-12
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.